FIELD: medicine.
SUBSTANCE: invention concerns ophthalmology and can be used for improvement of visual functions at primary open angle glaucoma with the normalised intraocular tension. Parabulbar introduction of the 5% Mexidol solution is performed within 10-12 days. In addition nimodipine is administered intravenously in a dose of 10 mg once a day within 10-12 days. Noopept is administered perorally in a dose of 10 mg 2 times a day within 1 month.
EFFECT: method allows strengthening antioxidising activity and circulation in eye tissues, increasing regenerating effect of nervous fibers.
8 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR THERAPEUTIC TREATMENT OF PRIMARY OPEN-ANGLE GLAUCOMA | 2003 |
|
RU2244528C1 |
| METHOD OF TREATING DISCIRCULATORY VERSION OF PRIMARY OPEN-ANGLE GLAUCOMA IN PEOPLE WITH MYOPIC REFRACTION | 2010 |
|
RU2449764C1 |
| METHOD OF TREATING OPEN-ANGLE GLAUCOMA | 2011 |
|
RU2494707C2 |
| METHOD OF TREATING ISCHEMIC TYPE OF PRIMARY OPEN-ANGLE GLAUCOMA IN INDIVIDUALS WITH NEAT SIGHT | 2010 |
|
RU2438670C1 |
| METHOD OF TREATMENT OF GLAUCOMA OPTIC NEUROPATHY | 2006 |
|
RU2335283C2 |
| METHOD OF TREATING ELDERLY AND SENILE GLAUCOMA OPTIC NEUROPATHY | 2009 |
|
RU2411033C1 |
| METHOD FOR IMPROVING VISION FUNCTION IN THE CASES OF PRIMARY OPEN ANGLE GLAUCOMA WITH NORMALIZED OPHTHALMIC TONUS | 2003 |
|
RU2259203C2 |
| METHOD FOR CORRECTION OF NEUROTROPHILIC CHANGES IN PATIENTS WITH PRIMARY OPEN-ANGLE GLAUCOMA AFTER CORONAVIRUS INFECTION | 2023 |
|
RU2814770C1 |
| ESTIMATION METHOD OF THE EFFICACY OF NEURORETINO PROTECTION OF PRIMARY OPEN-ANGLE GLAUCOMA ON THE BASIS OF DETERMINATION OF NEURON-SPECIFIC ENOLASE | 2018 |
|
RU2681935C1 |
| METHOD FOR ASSESSING THE EFFICACY OF NEURORETINOPROTECTION OF PRIMARY OPEN-ANGLE GLAUCOMA ON BASIS OF DETERMINING RATIO OF NEURAL MARKERS | 2018 |
|
RU2681654C1 |
